LTFS
CLVS

Ladenburg Thalmann Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$109K Buy
10,498
+5,703
+119% +$41.5K ﹤0.01% 2948
2019
Q3 		$19K Buy
4,795
+489
+11% +$3.96K ﹤0.01% 4085
2019
Q2 		$65K Buy
4,306
+1,160
+37% +$21K ﹤0.01% 3279
2019
Q1 		$77K Buy
3,146
+1,519
+93% +$38.1K ﹤0.01% 3084
2018
Q4 		$30K Buy
1,627
+1,013
+165% +$20.7K ﹤0.01% 3628
2018
Q3 		$18K Sell
614
-1,936
-76% -$75K ﹤0.01% 3985
2018
Q2 		$135K Hold
2,550
– – ﹤0.01% 2550
2018
Q1 		$135K Buy
2,550
+2,500
+5,000% +$146K ﹤0.01% 2550
2017
Q4 		$3K Sell
50
-114
-70% -$7.97K ﹤0.01% 4722
2017
Q3 		$13K Sell
164
-1,913
-92% -$152K ﹤0.01% 3953
2017
Q2 		$194K Sell
2,077
-73
-3% -$4.47K ﹤0.01% 2048
2017
Q1 		$137K Sell
2,150
-250
-10% -$15.2K ﹤0.01% 2191
2016
Q4 		$107K Buy
2,400
+400
+20% +$14.1K ﹤0.01% 2275
2016
Q3 		$72K Buy
+2,000
New +$42.9K ﹤0.01% 2498
2015
Q4 		– Sell
-13
Closed -$1K – 4824
2015
Q3 		$1K Buy
13
+3
+30% +$260 ﹤0.01% 4487
2015
Q2 		$1K Hold
10
– – ﹤0.01% 4561
2015
Q1 		$1K Sell
10
-200
-95% -$14.1K ﹤0.01% 4480
2014
Q4 		$12K Hold
210
– – ﹤0.01% 3328
2014
Q3 		$10K Sell
210
-5,015
-96% -$210K ﹤0.01% 3113
2014
Q2 		$216K Buy
+5,225
New +$269K 0.01% 1154

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CLVS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Clovis Oncology, Inc. (CLVS) stake by 119% in Q4 2019, buying an estimated $41.5K and bringing the position to 10,498 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Ladenburg Thalmann Financial Services first reported a position in CLVS in Q2 2014 and has held it in 20 quarters since. The position peaked at $216K in Q2 2014. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 10,498 shares of Clovis Oncology, Inc. worth $109K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 5,703 Clovis Oncology, Inc. shares in Q4 2019, an estimated $41.5K.
  • Clovis Oncology, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2948 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Clovis Oncology, Inc. in Q2 2014 and has held it in 20 quarters since.
  • Ladenburg Thalmann Financial Services's Clovis Oncology, Inc. position peaked at $216K in Q2 2014.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.